A roundup of the newest places to go and exhibitions to visit during the upcoming fashion week, running from Tuesday to ...

RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $75.00. The ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

Shares of Moderna Inc. MRNA slipped 3.43% to $65.69 Friday, on what proved to be an all-around mixed trading session for the ...

The billionaire entrepreneur and CEO of IT services company World Wide Technology remains bullish about the future of AI.

Shares of Moderna Inc. MRNA slipped 2.63% to $68.02 Thursday, on what proved to be an all-around favorable trading session ...

UCG / Contributor / Getty Images Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine. Moderna's Spikevax KP.2 targets the KP.2 variant of ...

Moderna Therapeutics (NASDAQ: MRNA) was once the darling of the healthcare space for investors. The company emerged as one of the biggest names of the COVID-19 pandemic with its vaccine.

Plus, we'll look at the how gas prices can affect elections and do the numbers on the new COVID vaccine in this week's ...

TORONTO - Health Canada has authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating variants of the virus. The mRNA vaccine, called Spikevax, has been ...

Today, the Lonza Board of Directors announced the nomination of Juan Andres and Eric Drapé as Independent Members of the Board. The Board will propose to shareholders the election of both nominees at ...

TORONTO — Health Canada authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Tuesday. We apologize, but this video has failed to load.